iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 4 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

0
Player Avatar dustbusterz (< 20) Submitted: 8/15/2007 10:13:24 PM : Underperform Start Price: $2.94 ICAD Score: -149.10

with no cash reserves,a dwindling net assets and othe financials, this dosen't look like a smart play to me. the company is still young and seems to be doing some things right,but has a long way to go before it would be a player. i see it under performing in the near term.

Member Avatar Bunsun02 (< 20) Submitted: 5/9/2011 1:50:01 PM
Recs: 0

Your comment displays a lack of understanding of the company. This is not a young company by any means. It went public almost 20 years ago.

Featured Broker Partners


Advertisement